RESULTS	In contrast , oxybutynin ER resulted in memory impairment , with significantly lower scores than placebo and darifenacin ( mean differences , -1.30 , p = 0.011 and -1.24 , p = 0.022 , respectively ) for delayed recall on the Name-Face Association Test at week 3 .\